Search Results Search Sort by RelevanceMost Recent Viewpoint Oct 2014 “We Can” Doesn’t Mean “We Should”: Aggressive Interventions to Prolong Pregnancy Stephen T. Chasen, MD Virtual Mentor. 2014;16(10):842-845. doi: 10.1001/virtualmentor.2014.16.10.oped2-1410. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010. Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038. State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.